Daclizumab or basiliximab

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Diabetes Mellitus, Type 1Type 1 Diabetes Mellitus

Phase 2

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

CompletedNCT00434850

National Institute of Allergy and Infectious Diseases (NIAID)Diabetes Mellitus, Type 1

Start: 2006-10-31End: 2013-11-30Updated: 2016-03-16

Phase 3

Efficacy of Islet After Kidney Transplantation

CompletedNCT00468117

National Institute of Allergy and Infectious Diseases (NIAID)Type 1 Diabetes Mellitus

Start: 2007-01-31End: 2017-07-05Updated: 2017-10-20

Related Papers

Identifying Promising Immunomodulators for Type 1 Diabetes (T1D) and Islet Transplantation.

2024-12-204 citations